Kbc Group Nv Heron Therapeutics, Inc. Transaction History

Kbc Group Nv

$33.1 Billion
Q3 2024

A detailed history of Kbc Group Nv transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, Kbc Group Nv holds 289,269 shares of HRTX stock, worth $323,981. This represents 0.0% of its overall portfolio holdings.

Number of Shares

289,269

Previous 289,269 -0.0%

Holding current value

$323,981

Previous $1.01 Million 43.08%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2024	SELL	$2.25 - $4.67 $749,169 - $1.55 Million	-332,964 Reduced 53.51%	289,269 $723,000
Q3 2022 Nov 08, 2022	SELL	$2.66 - $5.37 $885,684 - $1.79 Million	-332,964 Reduced 53.51%	289,269 $1.22 Million
Q2 2022 Feb 14, 2024	BUY	$2.3 - $6.29 $337,180 - $922,114	146,600 Added 30.82%	622,233 $1.74 Million
Q2 2022 Jul 26, 2022	BUY	$2.3 - $6.29 $337,180 - $922,114	146,600 Added 30.82%	622,233 $1.74 Million
Q4 2021 Feb 14, 2024	BUY	$8.35 - $12.6 $1.56 Million - $2.35 Million	186,364 Added 64.43%	475,633 $4.34 Million
Q4 2021 Feb 03, 2022	BUY	$8.35 - $12.6 $196,083 - $295,885	23,483 Added 5.19%	475,633 $4.34 Million
Q3 2021 Nov 10, 2021	BUY	$10.13 - $15.0 $4.58 Million - $6.78 Million	452,150 New	452,150 $4.83 Million
Q4 2019 Feb 11, 2020	SELL	$17.42 - $26.61 $9,581 - $14,635	-550 Closed	0 $0
Q3 2019 Nov 07, 2019	BUY	$16.36 - $21.39 $2,454 - $3,208	150 Added 37.5%	550 $10,000
Q2 2019 Dec 03, 2019	BUY	$16.93 - $26.22 $6,772 - $10,488	400 New	400 $7,000
Q2 2019 Jul 30, 2019	SELL	$16.93 - $26.22 $6,772 - $10,488	-400 Closed	0 $0
Q1 2019 Dec 03, 2019	BUY	$23.15 - $28.34 $9,260 - $11,336	400 New	400 $10,000
Q1 2019 May 10, 2019	SELL	$23.15 - $28.34 $9,260 - $11,336	-400 Closed	0 $0
Q4 2018 Dec 03, 2019	BUY	$22.03 - $32.01 $8,812 - $12,804	400 New	400 $10,000
Q4 2018 Jan 31, 2019	SELL	$22.03 - $32.01 $11,015 - $16,004	-500 Closed	0 $0
Q3 2018 Dec 03, 2019	BUY	$30.0 - $40.85 $15,000 - $20,425	500 New	500 $16,000
Q3 2018 Nov 14, 2018	SELL	$30.0 - $40.85 $15,000 - $20,425	-500 Closed	0 $0
Q2 2018 Dec 03, 2019	BUY	$26.4 - $42.0 $13,200 - $21,000	500 New	500 $19,000
Q2 2018 Aug 03, 2018	SELL	$26.4 - $42.0 $13,200 - $21,000	-500 Closed	0 $0
Q1 2018 Dec 03, 2019	BUY	$18.43 - $28.8 $9,215 - $14,400	500 New	500 $14,000
Q1 2018 May 09, 2018	SELL	$18.43 - $28.8 $9,215 - $14,400	-500 Closed	0 $0
Q4 2017 Dec 03, 2019	BUY	$14.8 - $18.85 $7,400 - $9,425	500	500 $9,000

Others Institutions Holding HRTX

# of Institutions

180

Shares Held

121M

Call Options Held

80.4K

Put Options Held

94.9K

View Full List

About HERON THERAPEUTICS, INC.

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $133M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

More about HRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kbc Group Nv, based on Form 13F filings with the SEC.

News

Stay updated on Kbc Group Nv with notifications on news.

Account